{"id":"https://genegraph.clinicalgenome.org/r/8d059264-276b-4658-922d-1c661c4b0135v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between BCS1L and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of September 9, 2019. Variants in BCS1L were first reported in humans with Leigh syndrome spectrum in 2001 (PMID: 11528392). Several pathogenic variants have been reported in ClinVar, and loss of function is the mechanism of disease for this gene. Evidence supporting this gene-disease relationship includes case-level data and experimental data. One proband with BCS1L  a homozygous pathogenic variant with Leigh syndrome spectrum has been reported in the 2001 publication (PMID: 11528392) to reach a case-level evidence score of 1.5. This gene-disease association is further supported by BCS1L protein interaction with other genes associated with Leigh syndrome spectrum, BCS1L expression in brain, mitochondrial alterations in patient cell lines, and a BCS1L mouse model exhibiting a neuropathological, biochemical, and developmental phenotype that recapitulates symptoms of Leigh syndrome spectrum reaching a experimental score of 5 pts. In summary, there is limited evidence to support the relationship between BCS1L and autosomal recessive Leigh syndrome spectrum. This classification was approved by the  NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 9, 2019 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/8d059264-276b-4658-922d-1c661c4b0135","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2019-09-19T15:53:15.896Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"The recommendation is that at least 3 probands are needed for a gene-disease clinical validity classification to be \"Moderate\".","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2604a4a1-b8bf-4e73-b4f3-8bb4ba2a5b08_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Functionality of mutations were assessed by utilizing complementation assays in a yeast model, specifically measuring complentation by assessing growth in glycerol and respiration in isolated mitochondria. The mutations found in patient 5 caused a two fold increase in doubling time, 3x lower NAD, and reduced NADH cytochrom C reductase.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/337530a3-693b-4a57-8db9-689544fc914d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11528392","rdfs:label":"DeLonlay Patient 5","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Cerebral magnetic resonance imaging showed lesions scattered from the basal ganglia to the brainstem compatible with a diagnosis of Leigh syndrome.","phenotypes":["obo:HP_0001263","obo:HP_0003128"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2604a4a1-b8bf-4e73-b4f3-8bb4ba2a5b08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11528392","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d78b8c5-598e-49d4-b1fc-ba12cd37338c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001318836.2(BCS1L):c.-40-123C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117989"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/954c3352-e576-4a65-bd38-6ac5087141ba","type":"EvidenceLine","dc:description":"As per Leigh Working group model scoring rubric, BCS1L knock in mouse received 0.5 pts for neuropathological evidence.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a75a8200-f570-4aa1-81f4-637dde321495","type":"Finding","dc:description":"Immunohistochemical analysis showed general mild astrogliosis throughout the brain.  In contrast to that, substantial astroglial activation was found highly localized to the primary somatosensory cortex which was reminiscent of patientâ€™s with BCS1L mutations. No signs of neurodegeneration were detected in the Bcs1l c.232A>G mouse brain. The volume of cerebral cortex and cerebellum was unchanged as was the thickness and the amount of neurons in the individual layers. (neuronal preservation in the cortex). This mouse demonstrated neuropathological findings similar to those associated with Leigh spectrum syndrome in humans","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28427446","rdfs:label":"BCS1L knock in model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/564c0eb9-3d1e-4179-b819-455b6a68a250","type":"EvidenceLine","dc:description":"As per Leigh Working group model scoring rubric, BCS1L knock in mouse received 2 pts for evidence of mitochondrial dysfunction, lactic acidemia, growth failure, and a shortened lifespan.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8e18a89-5f21-44f5-9b9c-862e219da9d8","type":"Finding","dc:description":"This mouse demonstrated evidence of mitochondrial dysfunction (reduced complex III activity) and lactic acidemia. Phenotypically, the mice showed growth failure and shortened lifespan. These phenotypes have been associated with Leigh spectrum syndrome in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21274865","rdfs:label":"BCS1L knock in mouse - Leveen","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab657334-7553-4407-984c-6a4c5bd910a5","type":"EvidenceLine","dc:description":"Patient derived cell culture model with evidence of mitochondrial dysfunction.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7367dbc0-743e-4c31-ab11-4b955738a329","type":"FunctionalAlteration","dc:description":"Blue native gel on patient muscle and fibroblasts demonstrated decreased levels of mitochondrial complex III although the deficiency was more severe in muscle. This pattern of increased severity in muscle also correlated with reduced Complex III deficiency muscle and fibroblasts (53% and 93% of lowest control value respectively).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19162478","rdfs:label":"Blazquez Fibroblast studies"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/68dda409-1e95-4266-82e8-cd5ec60dba3f","type":"EvidenceLine","dc:description":"This is the second patient derived cell culture model demonstrating mitochondrial dysfunction.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c57a2ba-bdc1-42a4-b4fd-25fb5f04d558","type":"FunctionalAlteration","dc:description":"The quantity of fully assembled CIII was investigated using antibodies directed against two CIII subunits (RISP and CORE1). There was an almost complete lack of fully as-sembled CIII and BCS1L (both oligomer and monomer) in patient cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28427446","rdfs:label":"Tegelberg Patient Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3b50d7db-1144-4187-a60c-72b45adb80bd_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a219b45-7f5a-4057-ba9d-626a270c2e1b","type":"EvidenceLine","dc:description":"The encoded protein shares a biochemical relationship or function with 1 gene product whose dysfunction is known to cause Leigh syndrome receiving a score of 0.5 pts","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d5d256e-21bb-4620-8761-7e8e92351f1d","type":"Finding","dc:description":"According to Leigh map, at least 1 other complex III assembly unit (TTC19) has been implicated in causing Leigh syndrome (Rahman et al 2017 PMID:27977873).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10508156","rdfs:label":"BCS1L Complex III assembly","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7e784dfe-f88e-4ccb-bf18-5dbf94f3585a","type":"EvidenceLine","dc:description":"Evidence showing that protein expression is disrupted in any tissue or cell type and/or evidence expression in the brain","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd616ade-6367-47b2-9620-4347b5b095cf","type":"Finding","dc:description":"The Human Protein Atlas demonstrates that BCS1L is ubiquitously expressed (https://www.proteinatlas.org/ENSG00000074582-BCS1L/tissue). Protein expression in the brain has been shown in the cerebral cortex, hippocampus, caudate, and cerebellum. Points can be awarded as this expression profile is consistent with areas of pathology in Leigh spectrum syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"Human Atlas brain expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Limited","sequence":252,"specifiedBy":"GeneValidityCriteria6","strengthScore":6.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/PohDNbvDos4","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:1020","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3b50d7db-1144-4187-a60c-72b45adb80bd-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}